TickerFacts.

Ernexa Therapeutics Inc. (ERNA): Cash & Equivalents

Annual figures by period end, from SEC filings.

$1.73M
As of 2024-12-31
-53.3%
3-year compound annual growth
-11.6%
5-year compound annual growth
-13.3%
10-year compound annual growth
$16.98M2010-12-31: $3.91M2011-12-31: $1.37M2012-12-31: $2.72M2013-12-31: $5.46M2014-12-31: $7.18M2015-12-31: $3.22M2016-12-31: $5.69M2017-12-31: $3.38M2018-12-31: $2.54M2019-12-31: $3.21M2020-12-31: $777.0K2021-12-31: $16.98M2022-12-31: $11.45M2023-12-31: $7.58M2024-12-31: $1.73M$1.73M
2010-12-31 Cash & Equivalents (USD) 2024-12-31
Period endedCash & EquivalentsChange YoYSource filing
2024-12-31$1.73M-77.2%2025-03-12, Balance as of period end
2023-12-31$7.58M-33.8%2025-03-12, Balance as of period end
2022-12-31$11.45M-32.6%2024-03-14, Balance as of period end
2021-12-31$16.98Mn/m2023-03-20, Balance as of period end
2020-12-31$777.0K-75.8%2021-03-11, Balance as of period end
2019-12-31$3.21M+26.5%2021-03-11, Balance as of period end
2018-12-31$2.54M-24.9%2020-03-19, Balance as of period end
2017-12-31$3.38M-40.6%2019-03-22, Balance as of period end
2016-12-31$5.69M+76.4%2018-03-09, Balance as of period end
2015-12-31$3.22M-55.1%2017-03-09, Balance as of period end
2014-12-31$7.18M+31.7%2016-03-15, Balance as of period end
2013-12-31$5.46M+100.5%2015-03-27, Balance as of period end
2012-12-31$2.72M+98.0%2014-03-31, Balance as of period end
2011-12-31$1.37M-64.8%2013-03-29, Balance as of period end
2010-12-31$3.91Mn/a2012-03-30, Balance as of period end